Profil
Alexander Bausch is the founder of Kinarus AG.
He currently holds the position of Vice Chairman & Chief Executive Officer at Kinarus Therapeutics Holding AG.
He obtained a doctorate degree from the University of Basel.
Aktive Positionen von Alexander Bausch
| Unternehmen | Position | Beginn |
|---|---|---|
Kinarus AG
 Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Founder | - |
Ehemalige bekannte Positionen von Alexander Bausch
| Unternehmen | Position | Ende |
|---|---|---|
| KINARUS THERAPEUTICS HOLDING AG | Chief Executive Officer | - |
Ausbildung von Alexander Bausch
| University of Basel | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |
Kinarus Therapeutics Holding AG
 Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland. | Health Technology |
